A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Prostate cancer is the most common type of cancer in men, and breast cancer the most common malignancy in women. Based on the improvements in understanding the biology of these cancers, treatment and ongoing development of new diagnostic tools aiming towards »personalized medicine« are under clinical evaluation. This article describes the improved value of one of the immunodetectable forms of the prostate-specific antigen (PSA), the so-called »complexed PSA« (cPSA), in detecting prostatedoi:10.2298/jmb0603235n fatcat:lzni3grimvc7dcq3yp7p3gt6ei